Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | MAN2B1 | O00754 | 2/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.42 |
| ▸ | CDC25B | P30305 | 1/20 | 0.42 |
| ▸ | MAN2A1 | Q16706 | 1/20 | 0.42 |
| ▸ | MAN1B1 | Q9UKM7 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21490940 | 1.00 | EPHX2 (0.48) | EPHX2ATMRIPK1MAN2B1CDC25A | |
| SCHEMBL28527056 | 0.90 | EPHX2 (0.47) | EPHX2RIPK1MAN2B1MAN2A1MAN1B1 | |
| SCHEMBL28519071 | 0.81 | CYP3A4 (0.57) | RIPK1SMN1; SMN2 | |
| SCHEMBL28519068 | 0.81 | CYP3A4 (0.57) | RIPK1SMN1; SMN2 | |
| SCHEMBL6050938 | 0.81 | ATM (0.49) | ATMCDC25ACDC25BHTTHDAC3 | |
| SCHEMBL11328925 | 0.81 | MTOR (0.61) | ATMCDC25ACDC25BHTTHDAC3 | |
| SCHEMBL24505282 | 0.79 | SMN1; SMN2 (0.50) | EPHX2RIPK1MAN2B1MAN2A1MAN1B1 | |
| SCHEMBL16481098 | 0.79 | RIPK1 (0.49) | EPHX2RIPK1MAN2B1MAN2A1MAN1B1 | |
| SCHEMBL6360986 | 0.79 | RIPK1 (0.49) | EPHX2RIPK1MAN2B1MAN2A1MAN1B1 | |
| SCHEMBL6360992 | 0.79 | RIPK1 (0.49) | EPHX2RIPK1MAN2B1MAN2A1MAN1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190321363-A1 | PROCESS FOR THE PREPARATION OF ELAGOLIX SODIUM AND ITS POLYMORPH | DR. REDDY'S LABORATORIES LIMITED (IN) | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190321363-A1 | PROCESS FOR THE PREPARATION OF ELAGOLIX SODIUM AND ITS POLYMORPH | PHAX, ELP1, DIS3 | EPHX2 1466/4885ATM 3454/4885RIPK1 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.